Senti Biosciences Holdings SNTI
Senti Biosciences Holdings signs $4.55M equity deal
Senti Biosciences Holdings (SNTI) filed an 8-K with the SEC on Nov 10, 2026, 4:36 pm ET. Source: the filing on SEC EDGAR.
Item 1.01 Enters material agreement, Item 3.02 Unregistered share sale
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001628280-26-072793
- $4.55 million equity commitment from CPIF II-9 Limited
- Funding scheduled in four installments through December 2027
- Shares to be purchased at Nasdaq-defined minimum price
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
